Condition
Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia clinical trials that are recruiting, at sites in 7 countries (most in United States (1), China (1), Germany (1)). By phase: Phase 1 (1), Early Phase 1 (1), Phase 2 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 7Countries
Newest Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Asciminib in children and young adults with relapsed or refractory Ph+ or ABL-class Ph-like ALL | Phase 1/2 | Sydney, New South Wales and 3 other locations | Recruiting | Feb 4, 2026 |
| Asciminib maintenance after alloHCT or CAR T for adults with Ph+ ALL | Phase 1 | Tampa, Florida | Recruiting | Nov 26, 2025 |
| ThisCART19A plus Olverembatinib for newly diagnosed Ph+ ALL | Early Phase 1 | Suzhou, Jiangsu and 1 other locations | Recruiting | Jul 20, 2025 |
| Comparing treatments for Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia | Phase 2 | Aachen and 84 other locations | Recruiting | Sep 29, 2023 |
All recruiting trials (4)
-
Asciminib in children and young adults with relapsed or refractory Ph+ or ABL-class Ph-like ALL
This study tests asciminib in kids and young adults with relapsed or refractory Philadelphia-positive or ABL-class Ph-like ALL to see if it is safe and helps treat the leukemia.
-
Asciminib maintenance after alloHCT or CAR T for adults with Ph+ ALL
Doctors will try asciminib in adults with Ph+ ALL who are in remission after an allogeneic stem cell transplant or CAR T therapy to check safety and find the best dose to help prevent relapse.
-
ThisCART19A plus Olverembatinib for newly diagnosed Ph+ ALL
A one-arm study tests whether ThisCART19A plus Olverembatinib can safely and effectively treat adults with newly diagnosed Philadelphia chromosome–positive ALL.
-
Comparing treatments for Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
This study tests whether Ponatinib or Imatinib, both with low-dose chemotherapy, can help adults with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia feel better, and looks at how Blinatumomab can be used for those who respond well or not to these treatments.
Related topics
Quick answers
How many Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 7 countries. The most sites are in United States (1 trial), China (1 trial), Germany (1 trial), Australia (1 trial), Israel (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Early Phase 1: 1, Phase 2: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.